Analysis of vaccinia virus temperature-sensitive I7L mutants reveals two potential functional domains

Virology Journal

Volumn 3, Issue , 2006, Pages

  Moerdyk, Megan J ^a   Byrd, Chelsea M ^b   Hruby, Dennis E ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b SIGA Technologies Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; ELECTRON MICROSCOPY; ENZYME ACTIVITY; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; TEMPERATURE; VACCINIA VIRUS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CATALYTIC DOMAIN; CONSERVED SEQUENCE; MUTATION; OPEN READING FRAMES; PEPTIDE HYDROLASES; TEMPERATURE; VACCINIA VIRUS; VIRAL CORE PROTEINS;

VACCINIA VIRUS;

EID: 33748916976     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-3-64     Document Type: Article

References (20)

1. Byrd CM, Bolken TC, Hruby DE: The vaccinia virus I7L gene product is the core protein proteinase. J Virol 2002, 76:8973-8976.
2. Byrd CM, Bolken TC, Hruby DE: Molecular dissection of the vaccinia virus I7L core protein proteinase. J Virol 2003, 77:11279-11283.
3. VanSlyke JK, Franke CA, Hruby DE: Proteolytic maturation of vaccinia virus core proteins; identification of a conserved motif in the N termini of the 4b and 25 K proteins. J Gen Virol 1991, 72:411-416.
4. VanSlyke JK, Whitehead SS, Wilson EM, Hruby DE: The multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein: a degenerate conserved cleavage motif within core proteins. Virology 1991, 183:467-478.
5. Whitehead SS, Hruby DE: Differential utilization of a conserved motif for the proteolytic maturation of vaccinia virus proteins. Virology 1994, 200:154-161.
6. Ansarah-Sobrinho C, Moss B: Role of the I7 protein in proteolytic processing of vaccinia virus membrane and core components. J Virol 2004, 78:6335-6343.
7. Szajner P, Jaffe H, Weisberg AS, Moss B: Vaccinia virus G7L protein interacts with the A30L protein and is required for association of viral membranes with dense viroplasm to form immature virions. J Virol 2003, 77:3418-3429.
8. Byrd CM, Hruby DE: A conditional-lethal vaccinia virus mutant demonstrates that the I7L gene product is required for virion morphogenesis. Virol J 2005, 2:4.
9. Kane EM, Shuman S: Vaccinia virus morphogenesis is blocked by a temperature sensitive mutation in the I7 gene that encodes a virion component. J Virol 1993, 67:2689-2698.
10. Lackner CA, D'Costa SM, Buck C, Condit RC: Complementation analysis of the Dales collection of vaccinia virus temperature-sensitive mutants. Virology 2003, 305:240-259.
11. Condit RC, Motyczka A: Isolation and preliminary characterization of temperature-sensitive mutants of vaccinia virus. Virology 1981, 113:224-241.
12. Condit RC, Motyczka A, Spizz G: Isolation, characterization, and physical mapping of temperature sensitive mutants of vaccinia virus. Virology 1983, 128:429-443.
13. Dales S, Milovanovitch V, Pogo BGT, Weintraub SB, Huima T, Wilton S, McFadden G: Biogenesis of vaccinia: isolation of conditional lethal mutants and electron microscopic characterization of their phenotypically expressed defects. Virology 1978, 84:403-428.
14. Ericsson M, Cudmore S, Shuman S, Condit RC, Griffiths G, Locker JK: Characterization of ts16, a temperature-sensitive mutant of vaccinia virus. J Virol 1995, 69:7072-7086.
15. Byrd CM, Bolken TC, Mjalli AM, Arimilli MN, Andrews RC, Rothlein R, Andrea T, Rao M, Owens KL, Hruby DE: New class of antiviral drugs that block viral maturation. J Virol 2004, 78:12147-12156.
16. Blasco R, Moss B: Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 1995, 158:157-162.
17. Lee P, Hruby DE: trans processing of vaccinia virus core proteins. J Virol 1993, 67:4252-4263.
18. Katz E, Moss B: Formation of a Vaccinia Virus Structural Polypeptide from a Higher Molecular Weight Precursor: Inhibition by Rifampicin. Proc Natl Acad Sci 1970, 66:667-684.
19. Byrd CM, Hruby DE: Development of an in vitro cleavage assay system to examine vaccinia virus I7L cysteine proteinase activity. Virol J 2005, 16:63.
20. Mangel WF, McGrath WJ, Toledo DL, Anderson CW: Viral DNA and a viral peptide can act as cofactors of adenovirus virion proteinase activity. Nature 1993, 361:274-27.